Multiple Sclerosis: A Rehabilitation Perspective



Similar documents
What is Multiple Sclerosis? Gener al information

Multiple Sclerosis: What You Need To Know. For Professionals

Global Multiple Sclerosis Market: Trends and Opportunities ( )

A blood sample will be collected annually for up to 2 years for JCV antibody testing.

Relapsing-remitting multiple sclerosis Ambulatory with or without aid

Managing the Symptoms of Multiple Sclerosis. Yolanda Harris, MSN, CRNP-AC CPODD Nurse Practitioner

06/06/2012. The Impact of Multiple Sclerosis in the Pacific Northwest. James Bowen, MD. Swedish Neuroscience Institute

CNS DEMYLINATING DISORDERS

The Nuts and Bolts of Multiple Sclerosis. Rebecca Milholland, M.D., Ph.D. Center for Neurosciences

Understanding. Multiple Sclerosis. Tim, diagnosed in 2004.

Progress in MS: Current and Emerging Therapies

A Definition of Multiple Sclerosis

The rising cost of prescription drugs to treat multiple sclerosis in upstate New York

Information About Medicines for Multiple Sclerosis

PCORI Workshop on Treatment for Multiple Sclerosis. Breakout Group Topics and Questions Draft

Integrating New Treatments: A Case Based Approach

How to S.E.A.R.C.H. SM for the Right MS Therapy For You!

Multiple Sclerosis & MS Ireland Media Fact Sheet

FastTest. You ve read the book now test yourself

Patient Group Input to CADTH

Disease Modifying Therapies for MS

Life with MS: Striving for Maximal Independence & Fulfillment

Information about medicines for multiple sclerosis

Trauma Insurance Claims Seminar Invitation

Global Multiple Sclerosis Drugs Market

Conflict of Interest Declaration. Overview of New Medications for Multiple Sclerosis. Assessment Question. Objectives 4/1/2011

Multiple Sclerosis Update. Bridget A. Bagert, MD, MPH Director, Ochsner Multiple Sclerosis Center

Symptoms can come and go; some are much more responsive to treatment whereas others are more difficult to manage.

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Proposed Health Technology Appraisal

Disease Modifying Therapies for MS

Using the MS Clinical Course Descriptions in Clinical Practice

New perception of disability including cognition, fatigue, pain and other impairments related to MS

Many people with MS use some form of conventional medical treatment, and many people also use complementary and alternative medicine (CAM).

The MS Disease- Modifying Drugs. Gener al information

We move our mission forward through Client Education & Services, Research, Advocacy and Professional Education.

Life with MS: Mastering Early Treatment

How to S.E.A.R.C.H. for the Right MS Therapy for You!

Multiple Sclerosis Jeffrey M. Gelfand, MD

MULTIPLE SCLEROSIS. Mary Beth Rensberger, RN, BSN, MPH Author

There's no cure for multiple sclerosis. However treatments can help treat attacks, modify the course of the disease and treat symptoms.

Disease Modifying Therapies (DMTs) in Multiple Sclerosis

Which injectable medication should I take for relapsing-remitting multiple sclerosis?

Multiple sclerosis (MS)

SECTION 2. Section 2 Multiple Sclerosis (MS) Drug Coverage

Committee Approval Date: December 12, 2014 Next Review Date: December 2015

Coping with Symptoms of Multiple Sclerosis

St. Luke s MS Center New Patient Questionnaire. Name: Date: Birth date: Right or Left handed? Who is your Primary Doctor?

Multiple Sclerosis (MS)

Study Support Materials Cover Sheet

Original Policy Date

Growth in revenue from MS drugs has been driven largely by price increases over the last several years.

Accommodation and Compliance Series. Employees with Multiple Sclerosis

Disclosures. Consultant and Speaker for Biogen Idec, TEVA Neuroscience, EMD Serrono, Mallinckrodt, Novartis, Genzyme, Accorda Therapeutics

MULTIMODAL THERAPY FOR MS- ASSOCIATED COGNITIVE DYSFUNCTION

Multiple Sclerosis Drug Discoveries - What the Future Holds

acquired chronic immune-mediated inflammatory condition of CNS. MS in children: 10% +secondary progressive MS: rare +primary progressive MS: rare

Michelle H. Cameron, M.D., P.T., M.C.R. Portland VA MS Center of Excellence- West, and Oregon Health & Science University

Clinical Commissioning Policy: Disease Modifying Therapies For patients With Multiple Sclerosis (MS) December Reference : NHSCB/D4/c/1

SOUTH TAMPA MULTIPLE SCLEROSIS CENTER

Summary chapter 2 chapter 2

Spine Care Centre (SCC) protocols for Multiple Sclerosis Update 1 August 2015

Resources for the Patient. Please print these out and give them to your patients with MS

Objectives. Definition. Epidemiology. The journey of an athlete

Choices Primary Progressive MS (PPMS)

The MS Disease- Modifying Medications GENERAL INFORMATION

Mellen Center for Multiple Sclerosis

Life with MS: Mastering Relationships with Family and Friends

Multiple Sclerosis (MS) Aprile Royal, Novartis Pharma Canada Inc. September 21, 2011 Toronto, ON

Medication Policy Manual. Topic: Plegridy, peginterferon beta-1a Date of Origin: December 12, 2014

Wellness for People with MS: What do we know about Diet, Exercise and Mood And what do we still need to learn? March 2015

AUBMC Multiple Sclerosis Center

6/3/2011. High Prevalence and Incidence. Low back pain is 5 th most common reason for all physician office visits in the U.S.

Lumbar Disc Herniation/Bulge Protocol

Understanding Relapse in Multiple Sclerosis. A guide for people with MS and their families

Pulmonary Rehabilitation Program - Home Exercise Program

SOUTH TAMPA MULTIPLE SCLEROSIS CENTER PATIENT/ CARE GIVER QUESTIONNAIRE

Medications for MULTIPLE SCLEROSIS Student Version

Supporting MS-Related Disability Claims to Private Insurers: The Physician s Role

DVD. Inside. living well. A Guide to Managing Multiple Sclerosis. Featuring Teri Garr

HOW RESEARCH INFLUENCES MS CARE TODAY? Patient Perspective Kimberly Haddock

Relapsing remitting MS

Treatment in Relapsing MS: Choosing Among the Options. Donald Negroski, MD

Knowledge Brochure Series MS & SYMPTOM MANAGEMENT

Fatigue Management in Neurology. Alison Nock MS Specialist Occupational Therapist

Multiple Sclerosis Therapeutics to Treatment Diversification, Increasing Efficacy, and Pipeline Innovation Combine to Drive Growth

New treatments in MS What s here and what s nearly here

Depression & Multiple Sclerosis

Managing Relapsing Remitting MS Risks & benefits of emerging therapies. Dr Mike Boggild The Walton Centre

Multiple Sclerosis (MS) is a disease of the central nervous system (including the brain and spinal cord) in which the nerves degenerate.

Medication Policy Manual. Topic: Aubagio, teriflunomide Date of Origin: November 9, 2012

LIVING WELL An Integrative Approach to Wellness with MS Member Application

MSTAC Initial Application

A Letter From the MS Coalition

It is much more than just feeling tired. It is described by people in many ways such as exhausting, overwhelming sleepiness and weakness.

Novel therapeutic approaches in multiple sclerosis Neuroprotective and remyelinating agents, the future of clinical trials in MS?

Depression & Multiple Sclerosis. Managing Specific Issues

ALL ABOUT SPASTICITY. Solutions with you in mind

What is MS? 1. disease that affects the central nervous. Is a disease that affects both white and gray matter

By Brittany White, PT and Kathy Adam, SLP

Medication Policy Manual. Topic: Aubagio, teriflunomide Date of Origin: November 9, 2012

Transcription:

Multiple Sclerosis: A Rehabilitation Perspective MICHELLE H. CAMERON, MD, PT Department of Neurology OHSU & Portland VA TED R. BROWN, MD, MPH Evergreen HealthCare 2012

Disclosures Dr Cameron: Has received honoraria from Teva neurosciences Has received consultation fees from DJO LLC and Mettler Electronics, Biogen Idec Has received research support from the National Multiple Sclerosis Society; the Multiple Sclerosis International Federation Currently has research support from the Department of Veterans Affairs Rehabilitation Research & Development Service; Acorda therapeutics; Collins Medical Trust

Disclosures Dr. Brown Has received honoraria from Teva Neurosciences, Acorda Therapeutics, Pfizer Has received consultation fees from Acorda, Biogen Idec, Bayer, Zars Pharmaceuticals Has received research support from Lilly and Forest Labs Currently has research support from the Acorda, Biogen and Teva

Objectives Understand that MS is caused by an interaction between the immune system and central nervous system Understand common presentations of MS, diagnostic principles and treatments Understand the principles of exercise for people with MS

Outline MS pathophysiology and epidemiology MS presentation, diagnosis and treatment Exercise in MS

MS Overview Lifelong Progressive No cure Transient disabilities and deficits (relapses) Sustained disability Persistent cognitive dysfunction

Pathophysiology of MS CNS disorder (brain, spinal cord, optic nerves) Symptoms separated in time and space Complex immune-mediated disorder

MS Plaque/Lesion Locations

Symptoms by Lesion Location Poor correlation Brain - Cognitive dysfunction - Double vision - Slurred speech - Tremor Optic nerve - Blurred vision or loss of vision Spinal cord - Weakness, numbness, bladder dysfunction

MS: Diagnosis Clinical diagnosis Objective evidence of CNS white matter lesions disseminated in time and space Neurologic history and exam Brain MRI Supportive Spinal MRI CSF: Elevated IgG index, oligoclonal bands

Epidemiology of MS 400,000 patients in USA, 2.5 million worldwide, ~1/700 (total 5000) in Oregon, ~ 9,000 in Washington Typical onset age 20-50 years, average 33-35 Female:male 2-4:1 Caucasians >> other ethnic groups Genetic predisposition: Identical twins: concordance 25-30% Geographic distribution: Increased prevalence in northern latitudes in N.A. and Europe

Prevalence rates per 100,000

MS course/sub-types

Relapses Usually new symptoms Sometimes significant worsening of an old symptom Lasts at least 24 hours Could be attributed to MS activity Preceded by stability or improvement for at least 30 days Average is 1-2 relapses per year for RRMS 40% of relapses leave residual disability at 3 months

Typical presenting symptoms Very varied but @ initial presentation Reduced sensation (33%*) Visual changes vision loss (16%), diplopia (7%) Weakness (13%) Unsteadiness when walking (5%) Poor balance (3%) Multiple symptoms (15%) Also Spasticity Incontinence Cognitive changes

Medical Treatment of MS Steroids to shorten clinical episodes but have no effect on long term outcome or recurrence rate Various medications to reduce relapse rate and slow progression of relapsing forms of MS Starting MS drug treatment early is recommended Drugs are less effective for progressive forms of MS Multiple symptomatic treatments

MS disease modifying therapies 1 st line, injectable Glatiramer (Copaxone) Interferons (Avonex, Rebif, Betaseron, Extavia) 2 nd line Natalizumab (Tyasbri) Monthly IV infusion Oral Fingolimod (Gilenya)

EXERCISE IN MS Good, bad, indifferent? The pros and cons of exercise for people with MS Good, better, best? What works Resources and recommendations

Pros and Cons of Exercise in MS Cons Fatiguing Uses up limited energy Overheating Pros Increases fitness Increases energy resource Reduces fatigue in the long run Can avoid overheating with appropriate precautions and exercise

Recommendations to Optimize Exercise Progress slowly Stop when performance declines Stay cool swimming, air-conditioning, cold drinks, cool shower before and after Take breaks

Benefits of Exercise Short-term the real motivators Reduced stress and tension A break Improved self-esteem and confidence Long-term Reduced fatigue Increased endurance Increased strength Increased flexibility Improved balance Increased cardiovascular fitness, reduced cardiovascular risk Improved mood Weight control Increased participation in activities

The Best Exercise for Your Patient Addresses their goals Reduced fatigue Endurance exercise Increased strength Resistance exercise Improved balance Standing exercise Cardiovascular fitness Aerobic exercise What they ll do! Alone, partner, class Indoor, outdoor

Clarify Exercise Goals Endurance Work on duration and repetition Resistance Weights, springs, bands Balance Standing, reduced support Fitness Aerobic, increased heart rate

Endurance Duration, Repetition

Strength - Resistance Exercise

Balance Standing Challenges

Fitness - Aerobic Exercise

Where? Physical therapy Assess goals Assess current abilities and safety Make a specific plan for exercise Home program Gym program Group program Follow to address concerns Gym Clubs Public In physical therapy clinic Groups Mall walking Hiking MS support groups Classes Tai Chi Dance Yoga

Why do patients drop out? Lack of motivation Lack of social support Time (perceived) Accessibility Improper exercise program Improper goal setting Exacerbation, illness, injury Fatigue

Keep the momentum: How to sustain a program Adequate sleep Exercise when energy is greatest Home program is essential Have indoor and outdoor options If feeling sluggish, reduce exercise for the day Quit smoking Keep track of progress

Instructions for staying cool Exercise at cooler times of day Use a fan/ A.C. Wear loose/light clothing Paced exercises Keep hydrated Consider pre-cooling Keep cooling packs/ garments/ ice handy

Managing MS fatigue All studies show positive or neutral effect of exercise on fatigue Give rest between exercises Stop when fatigued Teach the 2- hour rule Reduce program on fatigue days

Energy Conservation: the 4 P s Planning (organizer, day planner, wk planner, activity station (drop-zone)) Prioritizing (is this task necessary?) Pacing (budget your energy thru the day/wk) Positioning (proper body mechanics/workplace ergonomics)

Resources and Recommendations Local community center Gyms and health clubs MS society Books Exercises for Multiple Sclerosis Brad Hamler Websites National MS Society Google MS Exercise

Useful exercise precautions for MS patients Avoid exhaustion Avoid overheating Anticipate cognitive impairment High fall-risks

Imbalance and Falls in MS: Epidemiology >75% complain of balance abnormalities >50% fall in 3 months 12% had an injurious fall in 6 months 50% with an injurious fall ever Women with MS have increased risk of osteoporosis and fall-related fractures Balance abnormalities occur in those with minimal or undetectable impairments, as well as in those with significant impairments

Imbalance in MS 3 related abnormalities 1. Decreased ability to maintain position 2. Decreased ability to move outside of base of support 3. Delayed responses to postural displacements or perturbations

Strategies to Address Proprioceptive Deficits Enhance input TENS, strap or brace on leg Light touch cane Auditory input Tongue stimulation Practice Substitution Increase reliance on vision and vestibular Avoidance Avoid low light Avoid uneven surfaces

Canes etc. A cane or hiking poles to provide proprioceptive information more than support

Balance Training

Home Exercise

Safety strategies and home modifications Foot wear Home hazards Lights Trips

Reduce Environmental Hazards

Exercise for more disabled people Consider P.T. evaluation for getting started Consider O.T. directed program Stretching is a form of exercise- everybody needs that

Mental calisthenics Brain needs to be exercised, too Benefits of cognitive exercise proved in healthy seniors 5 studies in MS: none conclusive More research is needed

Mental Calisthenics Key areas Memory Concentration / attention Speed of thinking Reasoning Try to do it every day for at least 30 minutes

Assess and Address Speech and Swallowing problems

Summary & Conclusions MS is a chronic progressive neurological disease Several immune-based treatments, but no cure High fall-risk! Interventions that address proprioception and central integration are most likely to reduce imbalance and fall risk in MS

Conclusions Just do it! The best exercise is any exercise they ll do Clarify goals Remind patients to: Progress slowly but steadily Avoid overdoing and overheating Adapt